Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

8results about How to "Increased susceptibility" patented technology

High nickel alloy excellent in high welding temperature cracking resistance

ActiveEP4324939A4disadvantage in productivityincreased susceptibility
A high-Ni alloy having excellent weld-hot-cracking resistance includes, in mass%, Cr: 16-30%, Ni: 18-50%, Al: 0.01-1.0%, and Ti: 0.01-1.5%. In a first aspect of the invention, a relationship between number density of TiC precipitates having 1.0 µm or more of equivalent circle diameter and Mg content in steel satisfies formula (1) below. In a second aspect of the invention, S average concentration in oxide- and sulfide- inclusions is 0.70 mass% or more. In a third aspect of the invention, mass ratios of CaO, MgO, and Al2O3 in inclusions, where O or S is detected, satisfy formula (2), the mass ratios being respectively calculated from average concentrations of Ca, Mg and Al in the inclusions, (1) number density of TiC (number of pieces / mm2) ≤ 463 - 9.5 × Mg concentration in steel (mass ppm) and (2) [CaO - 0.6 × MgO] (mass%) / [CaO + MgO + Al2O3] (mass%) ≥ 0.20.
Owner:NIPPON STEEL CORPORATION

Application of ubiquitin-binding enzyme UBE2L6 in the prevention and treatment of porcine reproductive and respiratory syndrome and identification of porcine reproductive and respiratory syndrome-resistant pigs

The present invention discloses the application of ubiquitin-binding enzyme UBE2L6 in preventing and treating blue ear disease in pigs and identifying blue ear disease-resistant pigs. The present invention first discovered that after pigs are infected with PRRSV virus, the expression of ubiquitin-binding enzyme E2L6 will be promoted, and the expression level of UBE2L6 will increase significantly with the increase of infection time. At the same time, UBE2L6 gene knockdown promotes PRRSV replication, and UBE2L6 overexpression significantly inhibits virus replication; when the expression level of UBE2L6 in pigs is high, the pigs are resistant to PRRSV, and vice versa. Therefore, promoting UBE2L6 expression can improve pigs' resistance to blue ear virus, and UBE2L6 can be used as a standard for determining PRRSV susceptibility or resistance. The present invention lays a solid foundation for identifying pigs susceptible to PRRSV and resistant pigs by discovering new disease resistance / susceptibility genes of PRRSV hosts, which is conducive to the breeding of excellent strains of pigs and has important significance for the prevention and control of blue ear disease in pigs.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY +1

Method for establishing dengue hemorrhagic fever animal model for expressing hTim4

PendingCN119082202Anormal immune functionincreased susceptibilityFermentationVector-based foreign material introductionReceptorHaemorrhagic fever
The invention discloses a method for establishing a dengue hemorrhagic fever animal model for expressing hTim4, and belongs to the technical field of transgenic animal models. The establishment method of the dengue hemorrhagic fever animal model expressing the hTim4 comprises the following steps: transferring a vector containing a DNA fragment of the human-derived Tim4 into a mouse fertilized egg, carrying out transgenosis treatment on the mouse by using a Tol2 transgenosis system, implanting the survived fertilized egg into a false pregnancy receptor mouse, screening to obtain a positive mouse highly expressing the hTim4, and carrying out screening to obtain the dengue hemorrhagic fever animal model expressing the hTim4. And injecting dengue virus into the positive mouse intracranial. The clinical characteristics of the dengue hemorrhagic fever animal model expressing hTim4 highly conform to the clinical manifestation of human dengue hemorrhagic fever, and the model can be widely applied to the research of dengue hemorrhagic fever and the development of new drugs.
Owner:CHINA INST FOR FOOD & DRUG CONTROL (MEDICAL DEVICE STANDARDS MANAGEMENT CENT OF THE STATE FOOD & DRUG ADMINISTRATION CHINA GENERAL INST FOR MEDICAL PROD INSPECTION)

Kidney organoid and method for producing same

PendingEP4397749A4increased susceptibilityGastrointestinal cellsArtificial cell constructs
An object of the present invention is to a new method of producing a kidney organoid. The method for producing a kidney organoid is characterized by comprising culturing an early kidney organoid with a medium containing an RXR agonist and a PPAR agonist, wherein the kidney organoid includes matured proximal tubule cells.
Owner:OTSUKA PHARM CO LTD +1

Application of EF Hand family genes in improving tomato resistance to Phytophthora infestans

ActiveCN119824002BImprove resistance to Phytophthora infestansHighly pathogenic Phytophthora infestans resistancePlant peptidesFermentationBiotechnologyGenome editing
The application belongs to the technical field of molecular biology breeding, and particularly relates to application of EF Hand family genes in improving resistance of tomatoes to pathogenic Phytophthora. Two pathogenic Phytophthora disease-related genes are found and verified in tomatoes, the genomic nucleotide sequences of which are shown as SEQ ID NO: 1 and SEQ ID NO: 2 respectively, and the two genes both belong to members of the EF Hand gene family. By knocking out or silencing the above genes through gene editing technology, it is found that the tomato lines with the above genes knocked out or silenced have higher resistance to pathogenic Phytophthora compared with wild types. Meanwhile, the gene-edited tomato lines are not obviously affected in growth and development. Therefore, the application not only enriches the research on pathogenic Phytophthora disease-related genes in tomatoes, but also develops tomato lines with enhanced resistance to pathogenic Phytophthora by using the characteristics of the above genes, thereby providing new technical strategies and gene resources for tomato breeding.
Owner:AGRICULTURAL GENOMICS INSTITUTE AT SHENZHEN CHINESE ACADEMY OF AGRICULTURAL SCIENCES (SHENZHEN BRANCH GUANGDONG LABORATORY FOR LINGNAN MODERN AGRICULTURE)

Citrus Huanglongbing Resistance Regulatory Gene CsXCP2 and Its Application

ActiveCN121610524BIncrease resistanceReduced disease resistanceBiocideDisinfectantsBiotechnologyDisease
This invention discloses a gene regulating resistance to Huanglongbing (HLB) in citrus. CsXCP2 and its applications, the regulatory genes CsXCP2 The nucleotide sequence is shown in SEQ ID No. 1. The amino acid sequence of the protein CsXCP2 is shown in SEQ ID No. 2. This invention is the first to clone and identify the citrus cysteine ​​protease gene. CsXCP2 The function of [the substance] was revealed, showing that it is an important regulatory hub in the citrus immune signaling pathway and has antibacterial effects. This invention confirms that [the substance]... CsXCP2 By specifically enhancing the activation of the salicylic acid signaling pathway and directly inhibiting the growth of Huanglongbing fungus, citrus fruits are conferred resistance to Huanglongbing. Compared with existing findings, CsXCP2 This provides a new breeding target with a clear mechanism of action and significant disease resistance, which can alleviate the shortcomings of insufficient or limited effectiveness of existing resistance gene resources.
Owner:HUAZHONG AGRI UNIV

Application of dengue hemorrhagic fever animal model expressing hTim4

The invention discloses application of a dengue hemorrhagic fever animal model expressing hTim4, and belongs to the technical field of disease and medicine research. The dengue hemorrhagic fever animal model expressing the hTim4 can be applied to screening and / or evaluating drugs for treating and / or preventing the dengue hemorrhagic fever, or can be applied to researching a dengue hemorrhagic fever symptom mechanism, the dengue hemorrhagic fever animal model expressing the hTim4 is a mouse highly expressing human-derived Tim4, and a virus causing the dengue hemorrhagic fever symptom is a dengue virus. According to the application, the dengue hemorrhagic fever can be comprehensively evaluated in multiple aspects such as viremia, multi-organ bleeding and neutralizing antibody conditions, and support and assistance are provided for development and evaluation of drugs such as vaccines.
Owner:CHINA INST FOR FOOD & DRUG CONTROL (MEDICAL DEVICE STANDARDS MANAGEMENT CENT OF THE STATE FOOD & DRUG ADMINISTRATION CHINA GENERAL INST FOR MEDICAL PROD INSPECTION)

A test formulation and kit for diagnosing the risk of atrial fibrillation

This invention belongs to the field of biomedical technology, specifically relating to a diagnostic agent for the risk of new-onset atrial fibrillation in the elderly and its application. This invention discovers that plasma QUIN expression levels can be used as a quantitative screening standard for the risk of atrial fibrillation in the elderly population. When the QUIN expression level in a subject's biological sample is ≥88.02 ng / mL, the subject has a risk of developing atrial fibrillation within the next 10 years; the higher the QUIN level, the higher the risk. When the QUIN content in a subject's biological sample is ≥215.5 ng / mL and ≥280.4 ng / mL, respectively, the predicted cumulative risk of atrial fibrillation within 3 years is over 90% and over 95%, respectively. This technique of clearly stratifying subjects and quantifying risk assists in individualized intervention and clinical management, providing a reference for precision treatment.
Owner:SHANGHAI EAST HOSPITAL EAST HOSPITAL TONGJI UNIV SCHOOL OF MEDICINE